KRAS and cancer: By outlining the biological role of KRAS and its oncogenic mutations in cancer development, we review recent findings from proteomic studies, including global profiling, PTM characterization, spatial proteomics, and exosome analyses, in KRAS-mutant cancers, examining how different mutations alter the proteomic landscape in cancer cells and contribute to shaping the TME.